Stay updated on Efficacy Comparison: Victoza vs. OADs in T2D Clinical Trial
Sign up to get notified when there's something new on the Efficacy Comparison: Victoza vs. OADs in T2D Clinical Trial page.

Latest updates to the Efficacy Comparison: Victoza vs. OADs in T2D Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated to v3.4.3; previous revision v3.4.2 was removed.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedMinor system update: Revision updated from v3.4.1 to v3.4.2 with no changes to study details, eligibility criteria, or outcome data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page revision was updated from v3.4.0 to v3.4.1, indicating a small software update.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed.SummaryDifference0.0%

- Check90 days agoChange DetectedAdded a comprehensive Locations section listing numerous sites across the United States, Canada, and other regions, and updated the revision from v3.3.2 to v3.3.3. This clarifies where the study is conducted for easier reference by patients and investigators.SummaryDifference2%

Stay in the know with updates to Efficacy Comparison: Victoza vs. OADs in T2D Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Comparison: Victoza vs. OADs in T2D Clinical Trial page.